{
    "SPADE_N_13949": {
        "Clinical Information": [],
        "Patent Information": [],
        "Sequence Information": {
            "SPADE ID": "SPADE_N_13949",
            "Peptide Name": "Hill-Cec2 (UCLL1c, XXA, cecropin, natural AMPs; insects, arthropods, invertebrates, animals; Variant: H14)",
            "Source": "the Black Soldier Fly,Hermetia Illucens",
            "Family": "Not found",
            "Gene": "Not found",
            "Sequence": "GWWKRVFKPVEKFGQRVRDAGVQGIAIAQQGANVLATARGGPPQQ",
            "Sequence Length": 45,
            "UniProt Entry": "Ref",
            "Protein Existence": "Not found",
            "Biological Activity": [
                "Anti-Gram-"
            ],
            "Target Organism": "Not found",
            "Hemolytic Activity": "Not found",
            "Cytotoxicity": "Not found",
            "Binding Target": "Not found",
            "Linear/Cyclic": "Not found",
            "N-terminal Modification": "Not found",
            "C-terminal Modification": "Not found",
            "Stereochemistry": "Not found",
            "Structure Description": "Not found",
            "Formula": "Not found",
            "Mass": 4874.53,
            "PI": 11.57,
            "Hydrophobicity": -0.47,
            "Half Life": "Not found",
            "Function": "Not found",
            "Literature": [
                {
                    "Author": "Van Moll L, De Smet J, Paas A, Tegtmeier D, Vilcinskas A, Cos P, Van Campenhout L.2022",
                    "Reference": "Microbiol Spectr. 2022 Feb 23;10(1):e0166421. doi: 10.1128/spectrum.01664-21.Pub-Med.",
                    "Title": "In Vitro Evaluation of Antimicrobial Peptides from the Black Soldier Fly (Hermetia Illucens) against a Selection of Human Pathogens."
                }
            ],
            "Frequent Amino Acids": "GAQ",
            "Absent Amino Acids": "CHMOSUY",
            "Basic Residues": 7,
            "Acidic Residues": 2,
            "Hydrophobic Residues": 21,
            "Polar Residues": 26,
            "Positive Residues": 7,
            "Negative Residues": 2,
            "Net Charge": 5,
            "Comments": "Sequence analysis: APD analysis reveals this sequence is most similar (82.22%) toHill-Cec1GRAVY: -0.46; Mol W: 4874.591; Mol formula: C219H350N68O58; Mol Ex coeff: 11100.Activity: Active against S-aureus ATCC 6538 (MIC >32-64 uM), E. coli ATCC 8739 (MIC 1-2 uM), P. aeruginos (MIC 2-4 uM).Discovery: A similar sequence (H14) with one additional G (which is converted to C-terminal amidation here) has also been reported in a different paper. Peptide H14 is active against E. coli ATCC25922 (MIC 3.2 uM), K. pneumoniae ATCC700603 (MIC 6.5 uM), A.baumannii ATCC19606 (MIC 6.5 uM), P. aeruginosa CMCC10104 (MIC 12.9 uM), V. parahaemolyticus ATCC17802 (MIC 3.2 uM), E-faecalis ATCC29212 (MIC >25.9 uM), B. subtilis BNCC109047 (MIC 1.6 uM), S-epidermidis ATCC35984 (MIC >25.9 uM), S-aureus ATCC6538 (MIC >25.9 uM), and C-albicans ATCC10231 (MIC > 25.9 uM) (Peng et al., 2023). Updated 12/2023",
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_N_14006",
                    "Similarity": 1.0,
                    "Sequence": "GWWKRVFKPVEKFGQRVRDAGVQGIAIAQQGANVLATARGGPPQQG"
                },
                {
                    "SPADE_ID": "SPADE_N_13955",
                    "Similarity": 0.9777777777777777,
                    "Sequence": "GWRKRVFKPVEKFGQRVRDAGVQGIAIAQQGANVLATARGGPPQQG"
                },
                {
                    "SPADE_ID": "SPADE_N_13953",
                    "Similarity": 0.9555555555555556,
                    "Sequence": "GWWKRVFKPVEKFGQRVRDAGIQGIEIAQQGANVLATARGGPPQQ"
                }
            ]
        }
    }
}